These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35791133)
1. Role of Swept source optical coherence tomography in management of acute Vogt-Koyanagi-Harada's disease. Ganesh SK; Mistry S; Nair N Indian J Ophthalmol; 2022 Jul; 70(7):2458-2463. PubMed ID: 35791133 [TBL] [Abstract][Full Text] [Related]
2. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415 [TBL] [Abstract][Full Text] [Related]
3. Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study. Durmaz Engin C; Kayabasi M; Koksaldi S; Ipek SC; Saatci AO Photodiagnosis Photodyn Ther; 2023 Jun; 42():103634. PubMed ID: 37244453 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt-Koyanagi-Harada Disease. Chee SP; Chan SN; Jap A Ocul Immunol Inflamm; 2017 Aug; 25(4):528-532. PubMed ID: 27070488 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the optical coherence tomographic characters between acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy. Lin D; Chen W; Zhang G; Huang H; Zhou Z; Cen L; Chen H BMC Ophthalmol; 2014 Jun; 14():87. PubMed ID: 24974016 [TBL] [Abstract][Full Text] [Related]
6. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography. Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251 [TBL] [Abstract][Full Text] [Related]
7. Optical Intensities of Different Compartments of Subretinal Fluid in Acute Vogt-Koyanagi-Harada Disease. Lin D; Luo X; Meng L; Zhang G; Chen W; Chen H PLoS One; 2016; 11(2):e0149376. PubMed ID: 26871896 [TBL] [Abstract][Full Text] [Related]
9. Resolution of subretinal fluid with systemic corticosteroid treatment in acute Vogt-Koyanagi-Harada disease. Nazari H; Rao NA Br J Ophthalmol; 2012 Nov; 96(11):1410-4. PubMed ID: 22942161 [TBL] [Abstract][Full Text] [Related]
10. [The fundus manifestations and SD-OCT findings of patients with acute Vogt-Koyanagi-Harada disease]. Li B; Ye JJ; Zhang MF; Li DH Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):436-439. PubMed ID: 28606265 [No Abstract] [Full Text] [Related]
11. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease. Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924 [TBL] [Abstract][Full Text] [Related]
12. Enhanced depth imaging optical coherence tomography of the choroid in Vogt-Koyanagi-Harada disease. Nakayama M; Keino H; Okada AA; Watanabe T; Taki W; Inoue M; Hirakata A Retina; 2012; 32(10):2061-9. PubMed ID: 23095726 [TBL] [Abstract][Full Text] [Related]
13. FEATURES OF OPTICAL COHERENCE TOMOGRAPHY FOR THE DIAGNOSIS OF VOGT-KOYANAGI-HARADA DISEASE. Liu XY; Peng XY; Wang S; You QS; Li YB; Xiao YY; Jonas JB Retina; 2016 Nov; 36(11):2116-2123. PubMed ID: 27145255 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA). Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488 [TBL] [Abstract][Full Text] [Related]
15. Clinical and multimodal imaging characteristics of acute Vogt-Koyanagi-Harada disease unassociated with clinically evident exudative retinal detachment. Attia S; Khochtali S; Kahloun R; Ammous D; Jelliti B; Ben Yahia S; Zaouali S; Khairallah M Int Ophthalmol; 2016 Feb; 36(1):37-44. PubMed ID: 25939987 [TBL] [Abstract][Full Text] [Related]
17. Three-dimensional analysis of choroidal vessels in eyes with Vogt-Koyanagi-Harada disease before and after treatment. Sugitani K; Hirano Y; Kurobe R; Hirahara S; Yasukawa T; Yoshida M; Ogura Y Can J Ophthalmol; 2020 Dec; 55(6):500-508. PubMed ID: 32835675 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of Rituximab Treatment in Vogt-Koyanagi-Harada Disease Poorly Controlled by Traditional Immunosuppressive Treatment. Bolletta E; Gozzi F; Mastrofilippo V; Pipitone N; De Simone L; Croci S; Invernizzi A; Adani C; Iannetta D; Coassin M; Fontana L; Salvarani C; Cimino L Ocul Immunol Inflamm; 2022 Aug; 30(6):1303-1308. PubMed ID: 33793383 [TBL] [Abstract][Full Text] [Related]
19. Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease. Gupta V; Gupta A; Gupta P; Sharma A Am J Ophthalmol; 2009 Jan; 147(1):148-153.e2. PubMed ID: 18834577 [TBL] [Abstract][Full Text] [Related]